XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500

Original source ↗ | February 18, 2026 at 10:32 UTC | Finnhub - JNJ

No analysis available.

Ticker	Direction	Speaker	Thesis	Time
JNJ	NONE	Finnhub News	—	—